Literature DB >> 23250430

PPARγ is an E3 ligase that induces the degradation of NFκB/p65.

Yongzhong Hou1, France Moreau, Kris Chadee.   

Abstract

Nuclear factor-κB (NFκB) and peroxisome proliferator activated receptor-γ (PPARγ) are both transcription factors that perform distinct but overlapping roles in cellular regulation. Here we report that PPARγ acts as an E3 ubiquitin ligase, physically interacting with p65 to induce its ubiquitination and degradation. The ligand-binding domain of PPARγ interacts with the Rel Homology Domain region of NFκB/p65 to undergo robust ubiquitination and degradation that was independent of PPARγ transcriptional activity. Moreover, the ligand-binding domain of PPARγ delivered Lys48-linked polyubiquitin, resulting in the ubiquitination and degradation of p65. Lys28 was found to be critically important for PPARγ-mediated ubiquitination and degradation of p65, as it terminated both NFκB/p65-mediated pro-inflammatory responses and xenograft tumours. These findings demonstrate that PPARγ E3 ubiquitin ligase activity induces Lys48-linked ubiquitination and degradation of p65, and that this function is critical to terminate NFκB signalling pathway-elicited inflammation and cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250430     DOI: 10.1038/ncomms2270

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  37 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.

Authors:  T Shimada; K Kojima; K Yoshiura; H Hiraishi; A Terano
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

3.  The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.

Authors:  Lakshmanan Ganesh; Ezra Burstein; Anuradha Guha-Niyogi; Mark K Louder; John R Mascola; Leo W J Klomp; Cisca Wijmenga; Colin S Duckett; Gary J Nabel
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

Authors:  Anthony P Heaney; Manory Fernando; Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 5.  Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation.

Authors:  Gioacchino Natoli; Susanna Chiocca
Journal:  Sci Signal       Date:  2008-01-08       Impact factor: 8.192

6.  Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes.

Authors:  A Bas; G Forsberg; S Hammarström; M-L Hammarström
Journal:  Scand J Immunol       Date:  2004-06       Impact factor: 3.487

7.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

Review 8.  NF-kappaB in cancer: a marked target.

Authors:  Anning Lin; Michael Karin
Journal:  Semin Cancer Biol       Date:  2003-04       Impact factor: 15.707

9.  Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.

Authors:  Shuji Ogino; Kaori Shima; Yoshifumi Baba; Katsuhiko Nosho; Natsumi Irahara; Shoko Kure; Li Chen; Saori Toyoda; Gregory J Kirkner; Y Lynn Wang; Edward L Giovannucci; Charles S Fuchs
Journal:  Gastroenterology       Date:  2008-12-24       Impact factor: 33.883

10.  Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.

Authors:  Simona Saccani; Ivan Marazzi; Amer A Beg; Gioacchino Natoli
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  96 in total

1.  Enzyme enhancers for the treatment of Fabry and Pompe disease.

Authors:  Jan Lukas; Anne-Marie Pockrandt; Susanne Seemann; Muhammad Sharif; Franziska Runge; Susann Pohlers; Chaonan Zheng; Anne Gläser; Matthias Beller; Arndt Rolfs; Anne-Katrin Giese
Journal:  Mol Ther       Date:  2014-11-20       Impact factor: 11.454

2.  PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis.

Authors:  Caiyun G Li; Cathal Mahon; Nathaly M Sweeney; Erik Verschueren; Vivek Kantamani; Dan Li; Jan K Hennigs; David P Marciano; Isabel Diebold; Ossama Abu-Halawa; Matthew Elliott; Silin Sa; Feng Guo; Lingli Wang; Aiqin Cao; Christophe Guignabert; Julie Sollier; Nils P Nickel; Mark Kaschwich; Karlene A Cimprich; Marlene Rabinovitch
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

3.  Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.

Authors:  Masashi Mukohda; Ko-Ting Lu; Deng-Fu Guo; Jing Wu; Henry L Keen; Xuebo Liu; Pimonrat Ketsawatsomkron; Madeliene Stump; Kamal Rahmouni; Frederick W Quelle; Curt D Sigmund
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

4.  Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-κB pathway.

Authors:  Xinyu Liu; Zhangjie Yu; Xian Huang; Yi Gao; Xiuzhi Wang; Jianmin Gu; Song Xue
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  E3 ubiquitin ligase NKLAM positively regulates macrophage inducible nitric oxide synthase expression.

Authors:  Donald W Lawrence; Gail Gullickson; Jacki Kornbluth
Journal:  Immunobiology       Date:  2014-08-23       Impact factor: 3.144

6.  New Peroxisome Proliferator-Activated Receptor Agonist (GQ-11) Improves Wound Healing in Diabetic Mice.

Authors:  Jacqueline C Silva; Marina G R Pitta; Ivan R Pitta; Timothy J Koh; Dulcineia S P Abdalla
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-08-09       Impact factor: 4.730

Review 7.  Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.

Authors:  Pimonrat Ketsawatsomkron; Curt D Sigmund
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

Review 8.  Ubiquitin-mediated NFκB degradation pathway.

Authors:  Huimin Xu; Mengli You; Haifeng Shi; Yongzhong Hou
Journal:  Cell Mol Immunol       Date:  2014-10-27       Impact factor: 11.530

9.  LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.

Authors:  Laurent Calvier; Philippe Boucher; Joachim Herz; Georg Hansmann
Journal:  Circ Res       Date:  2019-04-26       Impact factor: 17.367

10.  Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).

Authors:  Sowmya P Lakshmi; Aravind T Reddy; Yingze Zhang; Frank C Sciurba; Rama K Mallampalli; Steven R Duncan; Raju C Reddy
Journal:  J Biol Chem       Date:  2013-12-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.